- Home
- ICU vs EVAX Comparison
ICU vs EVAX Comparison
Compare ICU & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- EVAX
- Stock Information
- Founded
- ICU 2018
- EVAX 2008
- Country
- ICU United States
- EVAX Denmark
- Employees
- ICU N/A
- EVAX N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICU Health Care
- EVAX Health Care
- Exchange
- ICU Nasdaq
- EVAX Nasdaq
- Market Cap
- ICU 15.9M
- EVAX 17.8M
- IPO Year
- ICU N/A
- EVAX 2021
- Fundamental
- Price
- ICU $0.31
- EVAX $5.33
- Analyst Decision
- ICU
- EVAX Strong Buy
- Analyst Count
- ICU 0
- EVAX 3
- Target Price
- ICU N/A
- EVAX $12.33
- AVG Volume (30 Days)
- ICU 919.2K
- EVAX 155.9K
- Earning Date
- ICU 11-13-2025
- EVAX 11-06-2025
- Dividend Yield
- ICU N/A
- EVAX N/A
- EPS Growth
- ICU N/A
- EVAX N/A
- EPS
- ICU N/A
- EVAX N/A
- Revenue
- ICU $881,000.00
- EVAX $7,650,000.00
- Revenue This Year
- ICU $820.00
- EVAX $129.34
- Revenue Next Year
- ICU $63.37
- EVAX N/A
- P/E Ratio
- ICU N/A
- EVAX N/A
- Revenue Growth
- ICU 1195.59
- EVAX 132.17
- 52 Week Low
- ICU $0.29
- EVAX $1.20
- 52 Week High
- ICU $3.07
- EVAX $12.15
- Technical
- Relative Strength Index (RSI)
- ICU 27.08
- EVAX 46.35
- Support Level
- ICU $0.30
- EVAX $4.85
- Resistance Level
- ICU $0.52
- EVAX $5.99
- Average True Range (ATR)
- ICU 0.05
- EVAX 0.49
- MACD
- ICU -0.01
- EVAX -0.12
- Stochastic Oscillator
- ICU 6.96
- EVAX 27.26
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.